2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Gu

2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Gu

Item

http://www.wikidata.org/entity/Q28249469

Q28249469

about

Endovascular revascularisation versus conservative management for intermittent claudication Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence Renovascular hypertension: is there still a role for stent revascularization?Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)Biomarkers and Genetics in Peripheral Artery Disease.Novel magnetic resonance imaging end points for physiologic studies in peripheral arterial disease: elegance versus practicality Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial.Prevalence of lower extremity peripheral artery disease among adult diabetes patients in southwestern Uganda.Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions.Use of hand-held Doppler ultrasound examination by podiatrists: a reliability study.Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.Novel screening metric for the identification of at-risk peripheral artery disease patients using administrative claims data.Uniform data collection in routine clinical practice in cardiovascular patients for optimal care, quality control and research: The Utrecht Cardiovascular Cohort.Pentoxifylline-Induced Thrombocytopenia: A Case Report.Validity and reliability of the ankle-brachial index by oscillometric blood pressure and automated ankle-brachial index Abdominal aortic aneurysm presenting as a claudication.Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease Impressive predictive value of ankle-brachial index for very long-term outcomes in patients with cardiovascular disease: IMPACT-ABI study.Lower extremity amputation in peripheral artery disease: improving patient outcomes.Association of depressive symptoms, trait anxiety, and perceived stress with subclinical atherosclerosis: results from the Chicago Healthy Aging Study (CHAS)Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study.Evaluation of peripheral arterial disease in prediabetes Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities).Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study Outcomes and characteristics of patients undergoing percutaneous angioplasty followed by below-knee or above-knee amputation for peripheral artery disease Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model Ankle/brachial index to everyone Implementation of a pilot accountable care organization payment model and the use of discretionary and nondiscretionary cardiovascular care.Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.Renal artery stenosis predicts coronary artery disease in patients with hypertension In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia.β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease.Association between the ankle-brachial index, intermittent claudication, and physical activity level: what is the influence on the functional capacity of patients with or at high risk of cardiovascular disease?Stroke patients with a past history of cancer are at increased risk of recurrent stroke and cardiovascular mortality.Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.Arrest of progression of pre-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by low level laser phototherapy.Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: The Tianliao Old People (TOP) study Comparisons of different metabolic syndrome definitions and associations with coronary heart disease, stroke, and peripheral arterial disease in a rural Chinese population

P2860

Q24197478-62E7B0CE-986F-4522-B85C-0699E4E78C23 Q26800276-F50D737B-8855-49E2-89FC-6C77F4C0A52D Q27000030-AEAE264F-CCD7-4D6F-9271-A6D69502E23B Q27004466-58BE09EF-6841-45FA-AD82-AD936E96BB87 Q30240841-6FCE0900-C3CA-482F-AF6F-DC562AA97995 Q30300189-CC81D3D4-FA5F-432E-BC5A-055F16B15EE6 Q30356518-B92B2CBF-B637-427E-88A2-BC10A19B7E2D Q30412493-ABECC2AD-AC32-405E-AA7E-7863375D7BA0 Q30416517-61F215D2-94FA-43BE-9179-85DD3971FD9C Q30660832-B0F5CBAC-DE36-4071-924D-CB164D302DF7 Q30821177-710EC92A-644E-4D47-94E5-907CE2A84617 Q31028283-A18B88F7-EAE9-4910-8F52-F5C588DCE323 Q31157319-E9AD4B6B-E160-435A-BA17-C46228572FDC Q33426421-4BE5B76D-DC12-4F87-A1EC-F91B7647EDFF Q33660732-FC6BB45F-85CA-4B57-9D1A-2E9DEAF48752 Q33694861-8239FF1E-8F91-4499-9CDA-DFB5F1FD8909 Q33734682-3290EA05-1B76-43BE-8A81-7FE0C45E5038 Q33803200-6D486C29-C5E9-45C5-B38A-71D9EAD8A81D Q33934939-83DB0105-8B99-4FDC-8A02-4ECB8CF9D1F7 Q34127720-6FEA9400-B081-47C9-9206-0621A441227A Q34307167-5348D08E-7B21-4AB2-B342-E0642C0EF06D Q34318596-9A17AAA0-0739-4654-B94D-E1C47D78DC11 Q34324759-36FD9502-118C-49BA-93DC-E95F85CE9118 Q34391653-07388F7A-B3D4-440A-82D8-5E68C10F48FC Q34411348-4A1EAECE-D256-4AAC-9274-B698BEF01372 Q34420835-5F69AEDE-FB07-4493-9F13-101E5CE045B1 Q34436787-434DBD03-AB05-4051-990E-8831A0E90C64 Q34460354-7735F824-1F7C-4B37-BC84-DC8E225807E7 Q34486105-BC92FB07-E08A-4110-AF8F-D973CA65F5AF Q34574675-C03920C5-1FB0-4BBA-A9EF-1DF7CA71AA59 Q34625055-0E6D3AEC-62BD-4AD9-8984-7518A394CFF5 Q34629843-DE2B9464-A2D6-4BCE-A99D-4F6D1C2A78D6 Q34816608-2122E8D8-F299-470B-9CEA-69F50CF83771 Q35026210-F536D385-4350-414C-A97B-2700C9DC4FE7 Q35043829-8452BD56-9F34-47BC-B9E6-E9E939357E13 Q35093584-BEA2A8C2-BA8F-4836-BE9B-5262FC6D1DED Q35184566-5D7A85C3-14A4-4CF9-A754-6B7BFAF1C339 Q35437077-EE9E7C84-F037-4A15-83C2-C2F4E55D1441 Q35535488-1ACE18C0-D2B0-45F9-A634-72856635EF61 Q35593376-91D3FE83-C04F-4AB6-B22C-0566D147A413

P2860

2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Gu

Item

http://www.wikidata.org/entity/Q28249469

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

2011 ACCF/AHA Focused Update o ...... tion Task Force on Practice Gu

@nl

type

Item

label

2011 ACCF/AHA Focused Update o ...... tion Task Force on Practice Gu

@nl

prefLabel

2011 ACCF/AHA Focused Update o ...... tion Task Force on Practice Gu

@nl

P1476

2011 ACCF/AHA Focused Update o ...... k Force on Practice Guidelines

@en

P2093

Alan T Hirsch

http://www.w3.org/2001/XMLSchema#string

Anton N Sidawy

http://www.w3.org/2001/XMLSchema#string

Christopher J White

http://www.w3.org/2001/XMLSchema#string

Gregory L Moneta

http://www.w3.org/2001/XMLSchema#string

Heather L Gornik

http://www.w3.org/2001/XMLSchema#string

Jafar Golzarian

http://www.w3.org/2001/XMLSchema#string

James C Stanley

http://www.w3.org/2001/XMLSchema#string

Jeffrey W Olin

http://www.w3.org/2001/XMLSchema#string

John V White

http://www.w3.org/2001/XMLSchema#string

Joshua A Beckman

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

Peripheral arterial disease detection, awareness, and treatment in primary care

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease

Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients?

Revascularization versus medical therapy for renal-artery stenosis.

P304

2020-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3377178

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JACC.2011.08.023

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan L. Halperin

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51685832

http://www.w3.org/2001/XMLSchema#string

P698

21963765

http://www.w3.org/2001/XMLSchema#string

P921

patient

P932

4714326

http://www.w3.org/2001/XMLSchema#string

2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Gu

about

P2860

P2860

2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Gu

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932